|
1
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society. Prostate Cancer
Statistics. 2013, http://www.cancer.org.
Accessed May 20, 2013
|
|
3
|
American Society of Clinical Oncology
Prostate Cancer Statistics. http://www.cancer.net/prostate.
Accessed May 20, 2013
|
|
4
|
Ito K: Prostate cancer in Asian men. Nat
Rev Urol. 11:197–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Arnold JT and Isaacs JT: Mechanisms
involved in the progression of androgen-independent prostate
cancers: It is not only the cancer cell's fault. Endocr Relat
Cancer. 9:61–73. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen J and Xu X: Diet, epigenetic, and
cancer prevention. Adv Genet. 71:237–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang NJ, Shin SH, Lee HJ and Lee KW:
Polyphenols as small molecular inhibitors of signaling cascades in
carcinogenesis. Pharmacol Ther. 130:310–324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Weng CJ and Yen GC: Chemopreventive
effects of dietary phytochemicals against cancer invasion and
metastasis: Phenolic acids, monophenol, polyphenol, and their
derivatives. Cancer Treat Rev. 38:76–87. 2012. View Article : Google Scholar
|
|
9
|
Russo A, Piovano M, Lombardo L, Vanella L,
Cardile V and Garbarino J: Pannarin inhibits cell growth and
induces cell death in human prostate carcinoma DU-145 cells.
Anticancer Drugs. 17:1163–1169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yim D, Singh RP, Agarwal C, Lee S, Chi H
and Agarwal R: A novel anticancer agent, decursin, induces G1
arrest and apoptosis in human prostate carcinoma cells. Cancer Res.
65:1035–1044. 2005.PubMed/NCBI
|
|
11
|
Cardile V, Scifo C, Russo A, Falsaperla M,
Morgia G, Motta M, Renis M, Imbriani E and Silvestre G: Involvement
of HSP70 in resveratrol-induced apoptosis of human prostate cancer.
Anticancer Res. 23C:4921–4926. 2003.
|
|
12
|
Russo A, Berretta M, Cardile V, Lombardo
L, Vanella L, Troncoso N, Garbarino J, Ignazio B and Li Volti G:
Pharmacological induction of heme oxygenase-1 reduces KB cell
viability: Role of carbon monoxide. J Carcinog & Mutagen. 2014,
http://dx.doi.org/10.4172/2157-2518.S8-009.
Accessed April 16, 2014
|
|
13
|
Waxman S: Differentiation therapy in acute
myelogenous leukemia (non-APL). Leukemia. 14:491–496. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vanella L, Barbagallo I, Acquaviva R, Di
Giacomo C, Cardile V, Abraham NG and Sorrenti V: Ellagic acid:
Cytodifferentiating and antiproliferative effects in human
prostatic cancer cell lines. Curr Pharm Des. 19:2728–2736. 2013.
View Article : Google Scholar
|
|
15
|
Breitman T, Collins SJ and Keene B:
Terminal differentiation of human promyelocytic leukemic cells in
promyelocytic leukemic cells in primary culture response to
retinoic acid. Blood. 57:1000–1004. 1981.PubMed/NCBI
|
|
16
|
Ohno R, Asou N and Ohnishi K: Treatment of
acute promyelocytic leukemia: Strategy toward further increase of
cure rate. Leukemia. 17:1454–1463. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vanella L, Di Giacomo C, Acquaviva R,
Barbagallo I, Cardile V, Kim DH, Abraham NG and Sorrenti V:
Apoptotic markers in a prostate cancer cell line: Effect of ellagic
acid. Oncol Rep. 30:2804–2810. 2013.PubMed/NCBI
|
|
18
|
Vanella L, Di Giacomo C, Acquaviva R,
Barbagallo I, Li Volti G, Cardile V, Abraham NG and Sorrenti V:
Effects of ellagic Acid on angiogenic factors in prostate cancer
cells. Cancers (Basel). 5:726–738. 2013. View Article : Google Scholar
|
|
19
|
Wang H, Race EJ and Shrikhande AJ:
Characterization of antho-cyanins in grape juices by ion trap
liquid chromatography-mass spectrometry. J Agric Food Chem.
51:1839–1844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Seeram NP, Cichewicz RH, Chandra A and
Nair MG: Cyclooxygenase inhibitory and antioxidant compounds from
crabapple fruits. J Agric Food Chem. 51:1948–1951. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Amorini AM, Fazzina G, Lazzarino G,
Tavazzi B, Di Pierro D, Santucci R, Sinibaldi F, Galvano F and
Galvano G: Activity and mechanism of the antioxidant properties of
cyanidin-3-O-beta-glucopyranoside. Free Radic Res. 35:953–966.
2001. View Article : Google Scholar
|
|
22
|
Lee HS: Characterization of major
anthocyanins and the color of red-fleshed Budd Blood orange (Citrus
sinensis). J Agric Food Chem. 50:1243–1246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsumoto H, Inaba H, Kishi M, Tominaga S,
Hirayama M and Tsuda T: Orally administered delphinidin
3-rutinoside and cyanidin 3-rutinoside are directly absorbed in
rats and humans and appear in the blood as the intact forms. J
Agric Food Chem. 49:1546–1551. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsuda T, Horio F and Osawa T: Absorption
and metabolism of cyanidin 3-O-beta-D-glucoside in rats. FEBS Lett.
449:179–182. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ichikawa H, Ichiyanagi T, Xu B, Yoshii Y,
Nakajima M and Konishi T: Antioxidant activity of anthocyanin
extract from purple black rice. J Med Food. 4:211–218. 2001.
View Article : Google Scholar
|
|
26
|
Kähkönen MP and Heinonen M: Antioxidant
activity of antho-cyanins and their aglycons. J Agric Food Chem.
51:628–633. 2003. View Article : Google Scholar
|
|
27
|
Briviba K, Abrahamse SL, Pool-Zobel BL and
Rechkemmer G: Neurotensin-and EGF-induced metabolic activation of
colon carcinoma cells is diminished by dietary flavonoid cyanidin
but not by its glycosides. Nutr Cancer. 41:172–179. 2001.
View Article : Google Scholar
|
|
28
|
Hagiwara A, Miyashita K, Nakanishi T, Sano
M, Tamano S, Kadota T, Koda T, Nakamura M, Imaida K, Ito N, et al:
Pronounced inhibition by a natural anthocyanin, purple corn color,
of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP)-associated colorectal carcinogenesis in male F344 rats
pretreated with 1,2-dimethylhydrazine. Cancer Lett. 171:17–25.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fimognari C, Berti F, Nüsse M,
Cantelli-Forti G and Hrelia P: Induction of apoptosis in two human
leukemia cell lines as well as differentiation in human
promyelocytic cells by cyanidin-3-O-beta-glucopyranoside. Biochem
Pharmacol. 67:2047–2056. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Serafino A, Sinibaldi-Vallebona P,
Lazzarino G, Tavazzi B, Rasi G, Pierimarchi P, Andreola F, Moroni
G, Galvano G, Galvano F, et al: Differentiation of human melanoma
cells induced by cyanidin-3-O-β-glucopyranoside. FASEB J.
18:1940–1942. 2004.PubMed/NCBI
|
|
31
|
Traverso N, Ricciarelli R, Nitti M,
Marengo B, Furfaro AL, Pronzato MA, Marinari UM and Domenicotti C:
Role of glutathione in cancer progression and chemoresistance. Oxid
Med Cell Longev. 2013:9729132013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vanella L, Di Giacomo C, Acquaviva R,
Santangelo R, Cardile V, Barbagallo I, Abraham NG and Sorrenti V:
The DDAH/NOS pathway in human prostatic cancer cell lines:
Antiangiogenic effect of L-NAME. Int J Oncol. 39:1303–1310.
2011.PubMed/NCBI
|
|
33
|
Sigala S, Tognazzi N, Rizzetti MC, Faraoni
I, Missale C, Bonmassar E and Spano P: Nerve growth factor induces
the re-expression of functional androgen receptors and p75(NGFR) in
the androgen-insensitive prostate cancer cell line DU145. Eur J
Endocrinol. 147:407–415. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Acquaviva R, Di Giacomo C, Sorrenti V,
Galvano F, Santangelo R, Cardile V, Gangia S, D'Orazio N, Abraham
NG and Vanella L: Antiproliferative effect of oleuropein in
prostate cell lines. Int J Oncol. 41:31–38. 2012.PubMed/NCBI
|
|
36
|
Romeo R, Giofrè SV, Garozzo A, Bisignano
B, Corsaro A and Chiacchio MA: Synthesis and biological evaluation
of furopyrimidine N,O-nucleosides. Bioorg Med Chem. 21:5688–5693.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Romeo R, Giofrè SV, Carnovale C, Campisi
A, Parenti R, Bandini L and Chiacchio MA: Synthesis and biological
evaluation of 3-hydroxymethyl-5-(1H-1,2,3-triazol) isoxazolidines.
Bioorg Med Chem. 21:7929–7937. 2013. View Article : Google Scholar
|
|
38
|
Calabrese V, Cornelius C, Trovato A,
Cavallaro M, Mancuso C, Di Rienzo L, Condorelli D, De Lorenzo A and
Calabrese EJ: The hormetic role of dietary antioxidants in free
radical-related diseases. Curr Pharm Des. 16:877–883. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Renis M, Calandra L, Scifo C, Tomasello B,
Cardile V, Vanella L, Bei R, La Fauci L and Galvano F: Response of
cell cycle/stress-related protein expression and DNA damage upon
treatment of CaCo2 cells with anthocyanins. Br J Nutr. 100:27–35.
2008. View Article : Google Scholar
|
|
40
|
Alimirah F, Chen J, Basrawala Z, Xin H and
Choubey D: DU-145 and PC-3 human prostate cancer cell lines express
androgen receptor: Implications for the androgen receptor functions
and regulation. FEBS Lett. 580:2294–2300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Litvinov IV, Antony L, Dalrymple SL,
Becker R, Cheng L and Isaacs JT: PC3, but not DU145, human prostate
cancer cells retain the coregulators required for tumor suppressor
ability of androgen receptor. Prostate. 66:1329–1338. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hagiwara Y, Kasukabe T, Kaneko Y, Niitsu N
and Okabe-Kado J: Ellagic acid, a natural polyphenolic compound,
induces apoptosis and potentiates retinoic acid-induced
differentiation of human leukemia HL-60 cells. Int J Hematol.
92:136–143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang Z, Chen H, Huo L, Yang Z, Bai Y, Fan
X, Ni B, Fang L, Hu J, Peng J, et al: Epigenetic inactivation and
tumor-suppressor behavior of NGFR in human colorectal cancer. Mol
Cancer Res. 13:107–119. 2015. View Article : Google Scholar
|
|
44
|
Panayiotidis M: Reactive oxygen species
(ROS) in multistage carcinogenesis. Cancer Lett. 266:3–5. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Meister A: Glutathione deficiency produced
by inhibition of its synthesis, and its reversal; applications in
research and therapy. Pharmacol Ther. 51:155–194. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shaw JP and Chou IN: Elevation of
intracellular glutathione content associated with mitogenic
stimulation of quiescent fibroblasts. J Cell Physiol. 129:193–198.
1986. View Article : Google Scholar : PubMed/NCBI
|
